Pulmonary complications are common following hematopoietic cell transplantation (HCT)
and contribute significantly to its morbidity and mortality. Diffuse alveolar hemorrhage is a …

Pulmonary infection is the leading cause of infectious morbidity and mortality in children with
immune defects. We provide a comprehensive review of lung infections in …

Approximately 2,500 pediatric hematopoietic cell transplants (HCTs), most of which are
allogeneic, are performed annually in the United States for life-threatening malignant and …

Lung injury after pediatric allogeneic hematopoietic cell transplantation (HCT) is a common
and disastrous complication that threatens long-term survival. To develop strategies to …

Impaired baseline lung function is associated with mortality after pediatric allogeneic
hematopoietic cell transplantation (HCT), yet limited knowledge of the molecular pathways …

The main purpose of this systematic review was to identify and synthesize evidence about
pulmonary complications following stem cell transplantation to raise awareness among …

Evaluation of a candidate for hematopoietic cell transplantation (HCT) is a complex process
with substantial intercenter variability. Although literature providing guidance for evaluating …

Diffuse alveolar hemorrhage (DAH) is a life-threatening complication of hematopoietic
cellular therapy (HCT). This study aimed to evaluate the effect of DAH treatments on …

Allogeneic hematopoietic cell transplantation (HCT) can be complicated by life-threatening
organ toxicity and infection necessitating intensive care. Epidemiologic data have been …

Plasma biomarkers associated with respiratory failure (RF) following hematopoietic cell
transplantation (HCT) have not been identified. Therefore, we aimed to validate early (7 and …